市場調査レポート
商品コード
1532134
胎児モニタリング市場:製品別、ポータビリティ別、方法別、用途別、エンドユーザー別、地域別、機会、予測、2017年~2031年Fetal Monitoring Market Assessment, By Product, By Portability, By Method, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
胎児モニタリング市場:製品別、ポータビリティ別、方法別、用途別、エンドユーザー別、地域別、機会、予測、2017年~2031年 |
出版日: 2024年08月13日
発行: Market Xcel - Markets and Data
ページ情報: 英文 246 Pages
納期: 3~5営業日
|
世界の胎児モニタリングの市場規模は、予測期間の2024年~2031年に7.02%のCAGRで拡大し、2023年の45億4,000万米ドルから2031年には78億1,000万米ドルに成長すると予測されています。出生率の増加、妊娠関連合併症の蔓延、技術の進歩などの要因が世界の胎児モニタリング市場を牽引しています。
胎児モニタリング機器は、妊娠中の胎児の健康と幸福を評価するために使用される重要なツールです。これらの機器には超音波システム、電子胎児モニター、胎児ドップラーなどがあり、ヘルスケアプロバイダーが胎児の心拍数、動き、母体の収縮をモニターするのに役立ちます。この成長は、早産や妊娠関連合併症の発生率の上昇、技術の進歩、妊産婦ケアに対する意識の高まりなど、いくつかの要因によってもたらされます。しかし、高コスト、規制上のハードル、妊産婦やヘルスケア提供者の限られた認識といった課題は、市場拡大の妨げになる可能性があります。現在、北米が最大の市場シェアを占めていますが、アジア太平洋地域が最も高い成長率を示すと予想されており、これはヘルスケアインフラの改善と高度なモニタリングソリューションに対する需要の高まりが影響しています。
2024年6月26日、食品医薬品局(FDA)はAIベースのハンドヘルド超音波診断装置についてClarius Health Corpに510(k)承認を与えました。Clarius OB AIは、30,000枚以上の胎児超音波画像で学習され、胎児生体測定値を計算するための適切なノギスの配置を自動化し、ユーザーはClariusアプリを介して患者の電子カルテに測定値を追加することができます。
妊娠関連合併症の有病率の増加は、胎児モニタリングデバイスの需要を大きく牽引しています。妊娠糖尿病、高血圧、早産などの状態はより一般的になっており、母親と胎児の両方の健康と安全を確保するためにモニタリングの強化が必要となっています。これらの合併症は深刻な健康リスクにつながる可能性があるため、医療提供者はタイムリーな介入を促進し、ハイリスク妊娠を効果的に管理するために、胎児モニタリングシステムへの依存度を高めています。技術の進歩により、より正確で効率的なモニタリングソリューションが可能になり、これらの機器の市場は成長すると予測されています。需要の急増は、妊婦の間で出生前ケアの重要性に対する意識が高まっていることや、胎児の健康状態や母体の健康状態を継続的に評価できる最新の胎児モニタリング技術の機能が後押ししています。妊娠糖尿病や子癇前症などの妊娠中の問題は、出産後数十年経過しても死亡率を高める可能性があります。妊娠中に深刻な問題を抱えた女性は、早期死亡のリスクが高いです。このような有病率は、世界の胎児モニタリング市場の成長につながります。
当レポートでは、世界の胎児モニタリング市場について調査し、市場の概要とともに、製品別、ポータビリティ別、方法別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。
Global fetal monitoring market is projected to witness a CAGR of 7.02% during the forecast period 2024-2031, growing from USD 4.54 billion in 2023 to USD 7.81 billion in 2031. Factors are driving the global fetal monitoring market such as increasing birth rates, prevalence of pregnancy related complications, and technological advancements.
Fetal monitoring devices are essential tools used to assess the health and well-being of a fetus during pregnancy. These devices include ultrasound systems, electronic fetal monitors, and fetal dopplers, which help healthcare providers to monitor fetal heart rates, movements, and maternal contractions. This growth is driven by several factors, including the rising incidence of preterm births and pregnancy-related complications, advancements in technology, and increasing awareness of prenatal care. However, challenges such as high costs, regulatory hurdles, and limited awareness among expectant mothers and healthcare providers may hinder market expansion. North America currently holds the largest market share, but Asia-Pacific is expected to exhibit the highest growth rate, influenced by improvements in healthcare infrastructure and rising demand for advanced monitoring solutions.
On 26th June 2024, the food and drug administration (FDA) granted 510(k) approval to Clarius Health Corp for its AI-based handheld ultrasound device. Clarius OB AI, has been trained on over 30,000 fetal ultrasound images, automates appropriate caliper placement for calculating fetal biometry measurements and allows users to add the measurements to patient electronic medical records via the Clarius app.
Increasing Prevalence of Pregnancy Related Complications
The increasing prevalence of pregnancy-related complications is significantly driving the demand for fetal monitoring devices. Conditions such as gestational diabetes, hypertension, and preterm labor have become more common, necessitating enhanced monitoring to ensure the health and safety of both the mother and fetus. As these complications can lead to serious health risks, healthcare providers are increasingly relying on fetal monitoring systems to facilitate timely interventions and manage high-risk pregnancies effectively. The market for these devices is projected to grow, with advancements in technology allowing for more accurate and efficient monitoring solutions. The surge in demand is fueled by rising awareness among expectant mothers about the importance of prenatal care and the capabilities of modern fetal monitoring technologies, which enable continuous assessment of fetal well-being and maternal health. Pregnancy problems, such as gestational diabetes or preeclampsia, may increase the chance of mortality even decades after delivery. Women who had serious problems during pregnancy have a higher risk of premature mortality. Such prevalence leads to growth of the global fetal monitoring market.
Technological Advancements to Drive Market Growth
Technological advancements in fetal monitoring are revolutionizing prenatal care, enhancing both the accuracy and convenience of monitoring fetal health. Innovations such as wearable devices, such as the abdominal patch developed by UC Irvine engineers in November 2022, allows expectant mothers to track fetal heart rates at home using a smartphone, promoting continuous monitoring without the need for trained technicians. The device utilizes an algorithm called Lullaby, which effectively isolates fetal electrocardiogram signals from maternal heartbeats, improving the clarity of data collected. Additionally, transabdominal fetal monitors are gaining traction, offering a non-invasive method that simplifies the monitoring process by using adhesive patches that do not require constant adjustments. These advancements improve the user experience and address challenges related to the global shortage of skilled healthcare professionals.
Portable Ultrasound Devices to Grow at a Fast Rate
Portable ultrasound devices are expected to see a significant increase in demand for fetal monitoring in the coming years due to several key factors. Handheld ultrasound systems are compact, lightweight, and easy for healthcare providers to use at the point-of-care, allowing for more frequent monitoring of fetal health. This is especially beneficial for high-risk pregnancies or in remote areas with limited access to traditional ultrasound machines. Technological advancements are enabling portable ultrasound devices to produce higher quality images comparable to cart-based systems. As the gap in functionality continues to decline, portable ultrasound will become an increasingly viable option for fetal monitoring. Artificial intelligence is being integrated with portable ultrasound to enhance diagnostic capabilities and guide treatment decisions, especially in emergency situations.
Konica Minolta Healthcare Americas, Inc. launched PocketPro H2, a wireless portable ultrasound device for general imaging in point-of-care applications, in July 2023. Konica Minolta Healthcare Americas Inc. partnered with Healcerion Co Ltd to commercialize the PocketPro H2 in the United States for urology and gynecology applications, bringing a new level of flexibility and affordability to ultrasound.
Hospitals to Dominate the Global Fetal Monitoring Market Share
Hospitals are equipped with advanced ultrasound technology and have specialists trained in interpreting fetal ultrasound images. They can provide comprehensive fetal monitoring throughout pregnancy, from early dating scans to detailed anatomy surveys and growth assessments. Hospitals have the capability to perform more specialized ultrasound exams such as fetal echocardiograms to evaluate the fetal heart. Additionally, hospitals are equipped to handle high-risk pregnancies that require closer monitoring, such as those with maternal conditions such as diabetes or preeclampsia, or fetal abnormalities detected in ultrasound. Portable ultrasound devices are increasingly being used in hospitals to provide point-of-care monitoring, allowing for more frequent checks on fetal well-being.
Future Market Scenario (2024-2031F)
Noninvasive fetal electrocardiography (ECG) and uterine contraction monitoring technologies are expected to bring novel metrics and potentially improved safety to obstetrics in coming years. These technologies filter ambient noise and focus on the fetal ECG waveform and uterine contraction patterns to provide more accurate monitoring. Fetal monitoring bands with innovative features like real-time data analysis, wireless connectivity, and portability are being introduced to make monitoring more convenient for providers and expectant mothers. These wearable devices allow for ambulatory monitoring outside the hospital setting.
Key Players Landscape and Outlook
The market witnessed some substantial market deals such as acquisitions, regulatory approvals, and product launches to expand the market share of key players. NeuroLogica Corp. launched the V6, their latest ultrasound system, in November 2023. The V6 provides full imaging capabilities in 2D, 3D, and color picture quality, with a focus on Women's Health and Urology. The V6 recently gained 510(k) clearance from the United States Food and Drug Administration for commercial usage, and it is intended to be cost-effective while meeting workflow and productivity requirements. A semi-automated tool based on deep learning that allows for one-click fetal growth measures, improving exam uniformity while minimizing keystrokes and allowing clinicians to focus more on patient care.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.